| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Nurix Therapeutics, Inc. | Director | Common Stock | 10,750 | $19,995 | $1.86 | 17 Sep 2025 | Direct |
| Biohaven Ltd. | Director | Stock Options (Right to buy) | 31,716 | 05 May 2025 | Direct | ||
| Nurix Therapeutics, Inc. | Director | Director Stock Option (right to buy) | 22,583 | 17 Sep 2025 | Direct | ||
| Biohaven Pharmaceutical Holding Co Ltd. | Director | Common Shares | 0 | 20 Dec 2021 | Direct | ||
| Biohaven Pharmaceutical Holding Co Ltd. | Director | Stock Options (Right to Buy) | 0 | 03 Oct 2022 | Direct |